Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AQST | US
0.25
5.05%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
19/09/2024
5.20
5.14
5.20
4.95
Aquestive Therapeutics Inc. a pharmaceutical company focuses on identifying developing and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108 a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and AQST-109 an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions including anaphylaxis. Further the company develops KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics Inc. was incorporated in 2004 and is headquartered in Warren New Jersey.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
90.3%1 month
82.3%3 months
81.6%6 months
76.6%-
-
-
-3.29
0.99
-1.81
6.62
-
-14.02M
473.51M
473.51M
-
0.27
-
51.80
-
8.63
14.21
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.10
Range1M
1.10
Range3M
2.96
Rel. volume
1.11
Price X volume
6.06M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 17.97 | 503.87M | 4.84% | n/a | 0.00% |
Elite Pharmaceuticals Inc | ELTP | Drug Manufacturers-Specialty & Generic | 0.38 | 405.83M | -1.43% | 18.00 | 0.00% |
Organogenesis Holdings Inc | ORGO | Drug Manufacturers-Specialty & Generic | 2.93 | 388.44M | 2.81% | n/a | 42.12% |
Aurora Cannabis Inc | ACB | Drug Manufacturers-Specialty & Generic | 5.77 | 315.39M | -1.37% | n/a | 0.00% |
Solid Biosciences Inc | SLDB | Drug Manufacturers-Specialty & Generic | 8 | 308.76M | 12.04% | n/a | 13.09% |
Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 2.02 | 306.37M | 3.59% | n/a | -471.04% |
ESSA Pharma Inc | EPIX | Drug Manufacturers-Specialty & Generic | 6.48 | 287.51M | 7.11% | n/a | 0.27% |
Cipher Pharmaceuticals Inc | CPHRF | Drug Manufacturers-Specialty & Generic | 11.03 | 284.72M | -3.50% | 12.74 | 0.00% |
Alpha Teknova Inc. Common Stock | TKNO | Drug Manufacturers-Specialty & Generic | 5.11 | 272.38M | 2.00% | n/a | 39.24% |
Procaps Group S.A. Ordinary Shares | PROC | Drug Manufacturers-Specialty & Generic | 1.8 | 203.08M | -0.55% | 3.63 | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 12.58 | 395.95M | 0.48% | 49.64 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 24.12 | 387.29M | 2.81% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.75 | 338.50M | 0.31% | 12.76 | 0.00% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 29.35 | 324.79M | 14.20% | 16.56 | -621.78% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 18.35 | 304.85M | 2.23% | 35.51 | 26.82% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.5 | 236.20M | -2.49% | 9.50 | 39.79% |
Unifi Inc | UFI | Textile Manufacturing | 7.59 | 138.98M | 6.60% | n/a | 52.56% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 37.9 | 107.64M | -1.76% | 5.90 | 15.58% |
Culp Inc | CULP | Textile Manufacturing | 6.35 | 79.31M | 5.31% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 5.78 | 62.58M | -6.47% | n/a | 54.96% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.81 | 16.67 | Cheaper |
Ent. to Revenue | 6.62 | 309.37 | Cheaper |
PE Ratio | - | 29.14 | - |
Price to Book | - | 12.81 | - |
Dividend Yield | - | 2.80 | - |
Std. Deviation (3M) | 81.57 | 75.12 | Par |
Debt to Equity | -3.29 | -0.93 | Cheaper |
Debt to Assets | 0.99 | 0.45 | Expensive |
Market Cap | 473.51M | 5.22B | Emerging |